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Abstract
Background: It has long been suggested that feedback signals from facial muscles influence emotional experience.
The recent surge in use of botulinum toxin (BTX) to induce temporary muscle paralysis offers a unique opportunity
to directly test this “facial feedback hypothesis.” Previous research shows that the lack of facial muscle feedback due
to BTX-induced paralysis influences subjective reports of emotional experience, as well as brain activity associated
with the imitation of emotional facial expressions. However, it remains to be seen whether facial muscle paralysis
affects brain activity, especially the amygdala, which is known to be responsive to the perception of emotion in
others. Further, it is unknown whether these neural changes are permanent or whether they revert to their
original state after the effects of BTX have subsided. The present study sought to address these questions by using
functional magnetic resonance imaging to measure neural responses to angry and happy facial expressions in the
presence or absence of facial paralysis.
Results: Consistent with previous research, amygdala activity was greater in response to angry compared to happy
faces before BTX treatment. As predicted, amygdala activity in response to angry faces was attenuated when the
corrugator/procerus muscles were paralyzed via BTX injection but then returned to its original state after the effects
of BTX subsided. This preliminary study comprises a small sample size and no placebo condition; however, the
A-B-A design affords the present sample to serve as its own control.
Conclusions: The current demonstration that amygdala responses to facial expressions were influenced by facial
muscle paralysis offers direct neural support for the facial feedback hypothesis. Specifically, the present findings
offer preliminary causal evidence that amygdala activity is sensitive to facial feedback during the perception of the
facial expressions of others. More broadly, these data confirm the utility of using BTX to address the effect of facial
feedback on neural responses associated with the perception, in addition to the experience or expression of
emotion.
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Background
It has long been suggested that feedback signals from facial
muscle activity associated with forming facial expressions
are critical to emotional experience [1,2]. This notion has
developed into what we now know as the facial feedback
hypothesis [3]. According to this hypothesis, our brain re-
ceives afferent feedback signals from facial muscles that
significantly influence how we process and experience
emotion [4]. Importantly, a number of psychological ex-
periments have shown support for the facial feedback hy-
pothesis [5-9].
In a classic demonstration by Strack and colleagues,
participants judged the funniness of cartoons while un-
knowingly contracting their zygomaticus (the facial
muscle used during smiling) by holding a pen in their
mouths [9]. This subtle manipulation influenced their
perception of the cartoons; such that they found the car-
toons to be funnier when contracting the zygomaticus
muscles compared to a control condition where the zygo-
maticus muscles were not contracted. This study offered
clear behavioral evidence that feedback signals from the fa-
cial muscles influence our emotional experiences.
Seminal studies such as this would be strengthened by
additional work seeking to establish a direct causal rela-
tionship between facial feedback and emotional phe-
nomena. Though Strack and colleagues convincingly
employed methods that protected against demand char-
acteristics (i.e., participants ostensibly were not aware of
the fact that they were being asked to smile) [9], there
are additional considerations when asking participants
to actively alter their facial muscle contractions. Specific-
ally, intentional alteration of facial muscle activity calls
for novel efferent signals to be sent to the facial muscles,
which might influence how we experience emotion inde-
pendent of any change in the afferent facial feedback sig-
nals to the brain. To put it another way, this method
does not allow us to distinguish between whether the
observed outcomes are due to a change in brain activity
that is responsible for producing the emotional facial ex-
pression (efferent) or a change in facial feedback signals
to the brain (afferent) [10,11]. Thus, it would be ideal to
leave the efferent brain signals intact while selectively
shutting down the afferent facial muscle signals.
Recent widespread cosmetic use of botulinum toxin
(BTX) type-A has allowed researchers to perform exactly
this separation of afferent and efferent signals, making it
possible to directly test causal factors related to facial
feedback. BTX induces a temporary paralysis of the
muscles at the injection site by inhibiting the release of
the neurotransmitter acetylcholine at the muscle nerves
[12]. By injecting BTX into the muscles that we use to
make emotional facial expressions, a “reversible lesion”
of target facial muscles can be temporarily created. This
effectively “severs” afferent feedback signals from these
muscles while leaving the efferent signals intact, thus
allowing us to study emotional experience and process-
ing devoid of facial muscle feedback.
The corrugator supercilii—an important component
of the glabellar muscles (the “frown muscles” between
the eyebrows) along with the procerus [13]—has been
implicated in the experience and processing of negative
emotions. One prototypical feature of an angry facial
expression is that the medial portions of the eyebrows are
pulled down using the corrugator supercilii muscles [14].
Using facial electromyography (EMG), researchers have
shown that corrugator activity is selectively potentiated
when viewing photos of angry facial expressions [15-17]. A
similar pattern of corrugator activity is found in response
to negative affective pictures [18-20] and sounds [20].
Based on this established link between corrugator activ-
ity and negative emotion, a number of recent studies have
used BTX to directly test the facial feedback hypothesis
and found that feedback from facial muscles influenced
subjective experience of emotion and emotional language
processing [10,21]. Other studies suggest that BTX injec-
tions mitigate depression symptoms and help elevate
mood in major depressive disorder patients [22,23]. Func-
tional neuroimaging studies are also beginning to explore
the relationship between facial feedback and responses to
emotional stimuli. The first such study assessed the effect
of BTX on the ability to imitate emotional expressions
[24]. Amygdala activity, and its coupling with brain stem
activity, was diminished when the corrugator muscle was
paralyzed with BTX as participants attempted to imitate
angry facial expressions. Taken together, these data suggest
that our emotional experiences as well as brain activity to
emotional stimuli can be influenced by feedback signals
from the facial muscles.
The present study sought to determine whether the ac-
tivity of the amygdala—a brain region within the medial
temporal lobe that is known to be sensitive to facial ex-
pressions of emotion, including anger [25]—in response to
angry facial expressions could be manipulated by BTX-
induced glabellar (i.e., corrugator/procerus) muscle paraly-
sis. Critically, when the effect of BTX injection subsides,
would amygdala activity in response to angry facial expres-
sions be restored? If so, this would provide strong evidence
in favor of the facial feedback hypothesis and shed further
light on its underlying neural mechanism. To this end, we
used functional magnetic resonance imaging (fMRI) in an
A-B-A design to assess neural responses to facial expres-
sions a total of three times: prior to BTX treatment,
shortly after BTX treatment (i.e., during corrugator/pro-
cerus paralysis), and after the effects of BTX had subsided.
We hypothesized that amygdala activity would be greater
to angry compared to happy facial expressions prior to
BTX administration, that these signal increases to angry
expressions would be mitigated by BTX, and that they
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would return to their pre-injection state (i.e., relatively en-




Initially, ten female volunteers were recruited through
the Department of Plastic Surgery at Dartmouth Hitch-
cock Medical Center. Our study sample was limited to
women for two reasons. First, reliable dosing is best ob-
tained in females, as men have a larger glabellar muscle
mass and require variable dosing. Second, the vast ma-
jority of BTX patients are women—for example, in 2013,
women received 94% of 6.3 million BTX treatments in
the United States [26]. Thus, we chose to focus on a fe-
male study sample. Of the ten volunteers, three did not
return for at least one of the subsequent sessions, and
thus, data reported here are from seven volunteers be-
tween the ages of 35–44 (mean age 40.43 ± 3.69 years).
All participants had corrected-to-normal vision and were
right handed. The current study was approved by the
Committee for the Protection of Human Subjects at
Dartmouth College, and written informed consent was
obtained from each subject prior to the experiment.
BTX injection
None of the participants had received BTX treatments
prior to the current study. All participants were injected
with botulinum toxin type-A a total of five times during
a single visit; twice in the corrugator supercilii on each
side and once in the procerus (a vertically oriented, mid-
line muscle which pulls the medial ends of the eyebrows
downward). The BTX was diluted as 100 units botu-
linum toxin/2 ccs non-preserved injectable saline. The
volume per injection was 0.1 cc/5 units, for a total dose
of 25 units. All participants received the injection 2–5
weeks after the first experimental session and then
returned to the lab 3–6 weeks after the first session for a
second experimental session. Finally, participants were
instructed to return at least 9 months after the injection,
a time known to be sufficient for the effect of BTX to
dissipate [13,27]. Our participants returned for their
third session an average of 54 (range 37–63) weeks after
their initial BTX injection.
Experimental paradigm
Participants were asked to participate in an fMRI scan-
ning session at each of the three time points. During
fMRI, each subject viewed a series of angry, happy, and
surprised facial expressions consisting of 18 identities (9
males and 9 females), which were selected from a stan-
dardized set (NimStim) [28]. The order of presentation
of all faces was randomized for each run. All of the stim-
uli were back-projected (Panasonic PT-D4000U DLP)
onto the center of a screen, which the participants viewed
using a mirror that was mounted on the head coil.
During each trial, photos of faces with angry, happy,
and surprised expressions were presented for 17, 50, and
1,000 ms, followed by a black-and-white pattern that
was presented for 250 ms, which served as a retinal
wipe. The length of intertrial intervals was jittered be-
tween 750 and 6,750 ms (average = 3,750 ms). Each run
consisted of 54 trials (18 trials for each emotion type,
presented in a pseudorandom order) lasting 4.5 total mi-
nutes, and the participants underwent three runs per
scanning session. During each trial, participants were
asked to report using a button box whether they thought
each of the faces they saw was positive or negative in
emotional valence (i.e., two-alternative forced choice
paradigm). We note that all trials (correct and error in
ratings) were included in the subsequent fMRI analysis
independent of their responses. For our purposes here,
we have collapsed the data across stimulus presentation
durations because our main focus was to elicit amygdala
activity to angry and happy faces, regardless of the differ-
ences in duration. Surprised faces and variable stimulus
durations were included as a part of a larger study, and
our goal was to have the participants work on the same
tasks as our previous investigation of surprise [17]. Here,
we report our preliminary findings on the effects of BTX
injections into the corrugator muscle on amygdala re-
sponses to angry and happy expressions.
Image acquisition
All participants were scanned at the Dartmouth Brain
Imaging Center, using a 3.0 Tesla Philips Intera Achieva
Scanner (Philips Medical Systems, Bothell, WA)
equipped with a SENSE birdcage head coil. Following
our standard imaging protocol that is known to
maximize signal to noise ratio in the amygdala in our
scanner, functional images were acquired using echo-
planar T2*-weighted imaging sequence. Each volume
consisted of 36 interleaved 3-mm-thick axial slices with
0.5-mm interslice gap (echo time [TE] = 35 ms, repetition
time [TR] = 2,000 ms, field of view [FOV] = 240 mm,
flip angle = 90°, voxel size = 3 × 3 × 3.5 mm). Anatom-
ical T1-weighted images were collected using a high-
resolution 3D magnetization-prepared rapid gradient
echo sequence, with 160 contiguous 1-mm-thick sagit-
tal slices (TE = 4.6 ms, TR =9.8 ms, FOV = 240 mm, flip
angle = 8°, voxel size = 1 × 0.94 × 0.94 mm).
fMRI data analysis
All fMRI images were processed using Statistical Para-
metric Mapping software (SPM5, Wellcome Department
of Imaging Neuroscience, London, UK). First, functional
blood-oxygen-level dependent (BOLD) data were pre-
processed using slice-time correction. Then, data were
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preprocessed to accommodate each subject’s head move-
ment for all six directions. We note here that none of the
participants showed head movement exceeding 2.5 mm or
2.5 degrees in any direction. Spatial normalization of the
functional images was performed by warping our data to
fit into standard space, using the Montreal Neurological
Institute (MNI)-152 template. In our final preprocessing
step, normalized functional images were smoothed using a
Gaussian kernel of 6-mm full width at half maximum.
At each voxel, the parameter estimates of event-related
activity were fit to a general linear model. Three types of
events were entered in the model—angry, happy, and sur-
prised faces. Covariates of no interest (a session mean, a
linear trend for each run, and six motion parameters de-
rived from realignment corrections) were also accounted
for in the general linear model. For the purposes of the
current study, we used angry and happy faces in further
analysis of variance (ANOVA) investigations. Surprised
faces were also included in the experimental design for an-
other experimental hypothesis. Since surprised faces have
ambiguous valence (i.e., they can be interpreted as having
either positive or negative valence), understanding of these
data will require further data collection in a greater
number of participants. Here, we present a 3 (Session: pre-
BTX, BTX, post-BTX) × 2 (Emotion: angry, happy) voxel-
wise ANOVA model of the data for the negative (angry)
and positive (happy) expressions, since even seven partici-
pants can offer consensus on the valence of these expres-
sions. To accommodate the 3 × 2 design (Session ×
Emotion), a voxelwise ANOVA model was constructed for
each subject, using linear contrasts (angry vs. baseline,
happy vs. baseline) generated for the three time points
(pre-BTX, BTX, and post-BTX). An implicit baseline was
derived from all unmodeled events in SPM—that is, all
events other than angry, happy, and surprised faces. They
were subsequently entered into a random effects model,
which allows population-based inferences to be made from
our data [29]. Given our specific hypothesis that amygdala
activity would follow an A-B-A pattern in response to
angry vs. happy faces, we searched for voxels that tracked
this pattern by entering a quadratic contrast vector in our
ANOVA model.
Since our aim was to investigate the impact of BTX on
amygdala activity specifically, we selected a significance
threshold of p < 0.05 corrected for multiple comparisons
over the amygdala volume (~4,500 mm3), which was de-
fined using the Automated Anatomical Labeling atlas
[30]. The significance threshold was calculated through
Monte Carlo simulations, using the AlphaSim tool in-
cluded with the AFNI software [31]. For all other brain
regions about which we did not have a priori hypoth-
eses, we imposed a statistical threshold of p < 0.001 (un-




A Session (pre-BTX, BTX, post-BTX) × Emotion (angry,
happy) ANOVA revealed a significant main effect of
Emotion (F(1,6) = 496.73, p <0.001; Figure 1). As ex-
pected, post hoc pairwise comparisons revealed that
across all three time points, angry faces were con-
sistently rated more negatively than happy faces (all
p’s < 0.001, Bonferroni corrected). We note here that ac-
curacy was calculated by combining 50 and 1,000 ms
data. Behavioral data from 17 ms were not included
because past research has shown that accuracy ratings
from 17 ms were not significantly different from
chance [17]. Angry faces were rated as negative on
86.5% of the trials, and happy faces were rated as
positive on 85.7% of the trials. The main effect of Ses-
sion and the Session × Emotion interaction were not
significant (all p’s > 0.05).
fMRI data
Voxelwise ANOVA results showed a significant Ses-
sion × Emotion interaction characterized by a quadratic
pattern of activity in the right amygdala (MNI 21, 3, −24;
t(36) = 3.28, p <0.05 corrected, cluster size = 432 mm
3) in
response to angry vs. happy faces (Figure 2). Specifically,
this quadratic pattern was characterized by significantly in-
creased right amygdala activity to angry vs. happy faces in
pre-BTX (p = 0.03, one-tailed) and post-BTX (p = 0.04,
one-tailed) conditions but no significant activity in the
BTX condition. No significant main effects of Session or
Emotion, as well as linear interaction effects were observed
in the amygdala. No other brain regions showed this quad-
ratic pattern of activity in response to angry vs. happy faces
at the pre-determined statistical threshold.
In an attempt to examine the possibility that the ob-
served quadratic effect was driven by amygdala activity
to angry faces or happy faces compared to baseline, we
further probed the right amygdala voxel cluster defined
by the voxelwise ANOVA (see Figure 2A) and analyzed
angry vs. baseline and happy vs. baseline separately. An
ANOVA with a planned quadratic contrast revealed that
right amygdala activity to angry vs. baseline (F(1,6) =
6.08, p = 0.049) and happy vs. baseline (F(1,6) =10.9, p =
0.016) had significant quadratic effects across sessions,
showing that the aforementioned voxelwise ANOVA re-
sults were not driven by angry faces or happy faces
alone (Figure 2). In fact, the quadratic pattern of amyg-
dala activity to angry faces had a U-shaped curve, which
matched the pattern observed in response to angry vs.
happy faces, whereas amygdala activity to happy faces
demonstrated an inverted U-shaped curve. There were
no significant linear effects across sessions for either
angry vs. baseline or happy vs. baseline comparisons (all
p’s > 0.05).
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Discussion
The aim of the current study was to investigate the ef-
fects of BTX-induced corrugator/procerus paralysis on
amygdala activity to angry faces by adapting an A-B-A
experimental design, a powerful method that allowed us
to determine the neural consequence of BTX treatment.
Consistent with our hypothesis, we observed diminished
amygdala activity to angry vs. happy faces when the fa-
cial muscles used to produce angry facial expressions
were paralyzed. Importantly, amygdala activity was re-
stored to its pre-BTX injection state after the effects of
BTX subsided. In other words, amygdala activity in re-
sponse to angry vs. happy faces was modulated in paral-
lel with the activity state of the corrugator supercilii and
the procerus. When the corrugator and procerus mus-
cles were unaffected by BTX, greater amygdala activity
to angry vs. happy faces was observed. However, when
the corrugator and procerus muscles were paralyzed via
BTX injection, amygdala activity in response to angry vs.
happy faces was attenuated. Our finding implies that
feedback signals from the corrugator supercilii and the
procerus to the brain are modulating amygdala activity.
Figure 1 Behavioral performance. Behavioral data showing that angry faces are consistently rated as negative (86.5%), and happy faces are
consistently rated as positive (85.7%), regardless of BTX injection. Error bars indicate standard error of the mean, which was computed by
removing between subject-variability to account for the within-subject design [32].
Figure 2 Right amygdala activity tracks BTX-induced corrugator/procerus paralysis. (A) Statistical map (coronal plane, Y = 3, p <0.01,
k = 7 voxels) depicting the right amygdala (MNI 21, 3, −24; t(36) = 3.28, p < 0.05 corrected, cluster size = 432 mm
3) that corresponded to the
effects of BTX. (B) Bar graph showing right amygdala activity to angry vs. happy faces, showing a distinctive quadratic pattern of activity (parameter
estimates for angry vs. happy faces were calculated by subtracting happy vs. baseline from angry vs. baseline). Red lines indicate right amygdala activity
to angry faces vs. baseline, and blue lines indicate right amygdala activity to happy faces. Error bars indicate standard error of the mean.
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According to the facial feedback hypothesis, our emo-
tional experience is modulated by feedback signals from
the facial muscles that we use to create expressions, and
this argument is supported, at least in part, by a number
of psychological studies [6,8-10,21]. Temporary paralysis
of facial muscles using BTX essentially cuts off all affe-
rent feedback signals from the injection site while
leaving the efferent signals untouched [12], providing re-
searchers with an ideal setup to directly test the facial
feedback hypothesis. Behavioral and psychophysiological
studies utilizing these unique properties of BTX have
also partially supported the facial feedback hypothesis
[10,21]. Here, we use the term “partially” because the re-
ports from the existing literature make it quite clear that
not all of our emotional experience can be accounted for
by afferent facial feedback signals [6,9,10,33]. At the
same time, however, these studies do show evidence sup-
porting the facial feedback hypothesis; that at least some
of our emotional experience is influenced by afferent sig-
nals from facial muscles.
Our data add further support to the facial feedback hy-
pothesis by offering direct neural evidence. We chose to
focus on the amygdala, which is known to be responsive
to biologically relevant and socially salient stimuli, in-
cluding facial expressions [34]. We specifically selected
angry faces to probe the amygdala, since the BTX treat-
ment in our study targeted the corrugator supercilii and
the procerus – the glabellar muscles that we use when
we frown and make angry faces. Prior to BTX treatment,
our participants demonstrated greater amygdala activity
to angry faces compared to happy faces. Similar activity
of the amygdala was observed when effects of BTX wore
off at least 9 months after its injection to the corrugator
supercilii and the procerus. It was only during the period
when BTX was active and the corrugator and procerus
muscles were paralyzed that we did not see greater
amygdala activity to angry vs. happy faces. This quad-
ratic pattern of amygdala activity is consistent with the
aforementioned behavioral and psychophysiological evi-
dence in favor of the facial feedback hypothesis. It is
clear from the data that the lack of afferent feedback sig-
nals from the corrugator supercilii and the procerus has
impacted how the amygdala responds to angry vs. happy
faces. The causal relationship we observe here is as fol-
lows: if there are no afferent feedback signals from the
facial muscles to the brain, then amygdala activity to
angry vs. happy faces is diminished. We believe that this
means amygdala activity to angry vs. happy faces is, at
least partially, relying on the feedback signals from the
corrugator supercilii and the procerus. This implies that
when we see an angry face, we detect and experience
negatively valenced emotion by contracting and flexing
the relevant muscles—the corrugator supercilii being the
most prominent one in this case—and our amygdala
uses these afferent signals to properly process the
information.
Our data showing diminished activity of the amygdala
due to BTX-induced paralysis of the corrugator/procerus
are consistent with the findings reported by Hennenlot-
ter and colleagues [24]. In their fMRI investigation, they
also observed attenuated amygdala activity to angry faces
when the participants were treated with BTX and had
their corrugator paralyzed, compared to their placebo-
injected controls [24]. There were slight differences as
well—for instance, they found BTX-induced attenuation
of amygdala activity only when the participants were
asked to imitate the facial expressions that were shown
on the screen, as opposed to just viewing them passively.
In our study, participants were not explicitly asked to
imitate the facial expressions they were viewing on the
screen, but we observed diminished amygdala activity
nonetheless. This discrepancy could stem from many
factors, among which include differences in the experi-
mental paradigm that was used to probe the amygdala.
Since we did not explicitly instruct the participants to ei-
ther imitate or not imitate the facial expressions, they
might have been less aware of their facial muscular
movements and thus less resistant to spontaneous elici-
tations of their own facial expressions when viewing
other people’s faces. This may have also influenced the
difference in the observed laterality of the amygdala—
that is, whereas Hennenlotter and colleagues report that
BTX affected the left amygdala [24], we found the right
amygdala to be modulated by BTX-induced paralysis of
the corrugator supercilii. Despite these relatively minor
differences, we believe our data are in the same vein as
the findings by Hennenlotter and colleagues, in the
sense that both provide neural evidence supporting the
facial feedback hypothesis [24]. Furthermore, an import-
ant contribution of the current study is the addition of a
third post-BTX condition. As the last ‘A’ in the A-B-A
design, this third condition allows us to directly test a
causal relationship between facial feedback signals and
amygdala activity and suggests that amygdala activation
changes due to BTX injections are not permanent but
rather reversible.
Another aspect of the current study that warrants dis-
cussion is the inclusion of happy faces in the analysis.
Happy faces were used as a direct comparison to angry
faces to gauge the level of amygdala activity—a common
strategy that has been employed in a number of fMRI
studies investigating the effects of negatively valenced fa-
cial expressions, such as anger or fear [35-37]. Upon
closer examination of the data, our observations revealed
that amygdala activity to happy faces actually showed an
opposite quadratic pattern compared to angry faces. By
subtracting amygdala activity to happy faces from angry
faces and thus calculating amygdala activity to angry vs.
Kim et al. Biology of Mood & Anxiety Disorders 2014, 4:11 Page 6 of 8
http://www.biolmoodanxietydisord.com/content/4/1/11
happy faces, the U-shaped quadratic pattern became
more prominent in our data. This inverted U-shaped
pattern of activity to happy faces emerges as a topic of
future inquiry, as BTX only had an effect on the corru-
gator supercilii and the procerus, not the zygomaticus
major—the facial muscle we use to smile—but nevertheless
had an impact on amygdala activity.
BTX-induced corrugator/procerus paralysis did not
alter the participants’ perception of the valence of angry
or happy faces. Regardless of BTX treatment, angry faces
were consistently rated as being negatively valenced, and
happy faces were consistently rated as being positively
valenced. This was expected, as judging such clearly
valenced facial expressions would not necessarily require
feedback signals from the corrugator, given that the par-
ticipants have prior experience and knowledge of the
meaning of angry and happy faces. It is important to
note that these behavioral data do not imply that affer-
ent signals from the corrugator/procerus are not being
used during processing of emotional facial expressions.
Rather, these results hint at our ability to utilize multiple
sources of information when making decisions on a
given clearly valenced face, such that the lack of corru-
gator feedback signal is compensated by other factors in-
cluding past experience and learned responses. Taking
into account the EMG findings that show increased cor-
rugator activity to angry facial expressions [15-17], nega-
tive pictures [18-20] and sounds [20], as well as other
BTX-induced corrugator paralysis studies demonstrating
behavioral effects such as impaired negative emotional
language processing (i.e., significantly delayed reading
times for sentences describing angry and sad situations)
[21] and diminished subjective emotional experience in
response to mildly positive video clips [10], it is clear
that the feedback signals from the corrugator impact our
emotional experiences, and it is beneficial to interpret
our data within this context.
Limitations of the current study include the relatively
small sample size. While within subject repeated mea-
sures (i.e., A-B-A design) mitigates this limitation to an
extent, having a larger sample size, as well as a control
group that is also cosmetically treated but without par-
alysis (see [10]) would strengthen the study. In addition,
the present results might generalize only to females who
would voluntarily report for BTX treatment. Next, it
should be noted that the participants were exposed to
surprised faces along with angry and happy faces during
the experiment, and so the results reported here for
happy and angry expressions could depend on the pres-
ence of surprised expressions in the experimental context.
Finally, the current A-B-A design comprised uneven time
intervals between each repeated measure, raising the pos-
sibility that the decrement in responses between pre-BTX
and BTX (3–6 weeks) might be due to response
habituation alone compared to the longer BTX and post-
BTX interval (9 months). However, previous studies exam-
ining the test-retest reliability of amygdala BOLD activity
to angry and fearful faces report reliable responsivity for
both short (2 weeks; [38]) and long (1 year; [39]) time
intervals.
Conclusions
To summarize, our data support the facial feedback hy-
pothesis by offering neural evidence concerning the causal
relationship between activity in the corrugator/procerus
muscles and in the amygdala. Using BTX to temporarily
paralyze facial muscles, we have found that the amygdala
closely tracks the state of the corrugator/procerus by
displaying a quadratic pattern of activity. Specifically,
amygdala responses to angry faces were diminished by
BTX-induced corrugator/procerus paralysis but reverted
to pre-BTX injections levels once the effect of the drug
wore off. These findings offer preliminary causal evidence
that amygdala activity is sensitive to facial feedback during
the perception of the facial expressions of others.
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